Skip to Content
Merck
CN
  • Protocol for Application, Standardization and Validation of the Forskolin-Induced Swelling Assay in Cystic Fibrosis Human Colon Organoids.

Protocol for Application, Standardization and Validation of the Forskolin-Induced Swelling Assay in Cystic Fibrosis Human Colon Organoids.

STAR protocols (2020-10-29)
Annelotte M Vonk, Peter van Mourik, Anabela S Ramalho, Iris A L Silva, Marvin Statia, Evelien Kruisselbrink, Sylvia W F Suen, Johanna F Dekkers, Frank P Vleggaar, Roderick H J Houwen, Jasper Mullenders, Sylvia F Boj, Robert Vries, Margarida D Amaral, Kris de Boeck, Cornelis K van der Ent, Jeffrey M Beekman
ABSTRACT

This protocol describes the isolation, handling, culture of, and experiments with human colon stem cell organoids in the context of cystic fibrosis (CF). In human colon organoids, the function of cystic fibrosis transmembrane conductance regulator (CFTR) protein and its rescue by CFTR modulators can be quantified using the forskolin-induced swelling assay. Implementation procedures and validation experiments are described for six CF human colon organoid lines, and representative CFTR genotypes are tested for basal CFTR function and response to CFTR-modulating drugs. For complete details on the use and execution of this protocol, please refer to Dekkers et al (2016) and Berkers and van Mourik (2019).

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
SB 202190, ≥98% (HPLC)
Sigma-Aldrich
Dulbecco′s Phosphate Buffered Saline, Modified, without calcium chloride and magnesium chloride, powder, suitable for cell culture
Sigma-Aldrich
Nicotinamide, BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
N-Acetyl-L-cysteine, suitable for cell culture, BioReagent
Sigma-Aldrich
Dimethyl sulfoxide, anhydrous, ≥99.9%